Mast-Cell Stabilizing Effects of Olopatadine

Phase 4

Completed

• Conditions: Allergic Conjunctivitis

• Registration Number: NCT00389025
• Lead Sponsor: Alcon Research

Brief Summary

To assess the effects of olopatadine of the release of mast cell histamine

Detailed Description

Not available

Study Timeline

• Study Start: 2006-10
• Study First Submitted: 2006-10-13
• Study First Submitted QC: 2006-10-16
• Study First Posted: 2006-10-17
• Primary Completion: 2007-04
• Status Verified: 2010-01
• Last Update Submitted: 2016-11-18
• Last Update Posted: 2016-11-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• Asymptomatic and not using any topical or systemic medication

Exclusion Criteria

• Age

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Tear histamine

Secondary Outcome Measures

Name	Time	Method
Tear cytology, subject evaluation of ocular itching, investigators evaluation of ocular redness

Trial Locations

Locations (1)

Padova Site; 🇮🇹 Padova, Italy